导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.02% | 2477/4773 |
| 近一周 | -3.15% | 3775/5462 |
| 近一月 | -8.08% | 4092/5421 |
| 近一季 | -14.70% | 4188/5209 |
| 近半年 | -2.84% | 2046/4920 |
| 近一年 | 1.50% | 2322/4366 |
| 近两年 | 62.03% | 1158/2954 |
| 近三年 | 31.91% | 972/2253 |
| 成立以来 | 605.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.63% 2400/4961 |
21.96% 1146/5312 |
- - |
- - |
| 2025 | 27.71% 1542/4813 |
-0.71% 2372/3635 |
-0.60% 2973/4076 |
32.03% 1099/4524 |
-1.99% 3056/4813 |
| 2024 | 13.36% 1145/3463 |
0.40% 985/2808 |
-3.50% 1382/3014 |
21.13% 614/3129 |
-3.41% 2339/3463 |
| 2023 | -16.30% 1677/2656 |
4.65% 894/2280 |
-6.43% 1638/2385 |
-7.84% 1631/2515 |
-7.25% 2101/2655 |
| 2022 | -25.39% 1315/2207 |
-19.10% 1431/1919 |
9.44% 285/2016 |
-17.22% 1563/2113 |
1.80% 1133/2208 |
| 2021 | -0.28% 747/1822 |
-4.97% 900/1255 |
10.86% 427/1330 |
-8.16% 1111/1466 |
3.07% 477/1822 |
| 2020 | 50.86% 163/1250 |
-5.90% 444/1028 |
22.64% 203/1067 |
10.62% 529/1164 |
18.18% 100/1184 |
| 2019 | 56.81% 63/1092 |
38.85% 60/754 |
-3.30% 387/804 |
4.77% 184/850 |
11.47% 59/918 |
| 2018 | -34.18% 566/834 |
- - |
- - |
- - |
-14.41% 584/691 |
| 2017 | 27.67% 85/714 |
- - |
- - |
- - |
- - |
| 2016 | -14.85% 342/605 |
- - |
- - |
- - |
- - |
| 2015 | 23.02% 101/575 |
- - |
- - |
- - |
- - |
| 2014 | 34.08% 152/237 |
- - |
- - |
- - |
- - |
| 2013 | -3.15% 74/186 |
- - |
- - |
- - |
- - |
| 2012 | 2.27% 100/140 |
- - |
- - |
- - |
- - |
| 2011 | -30.54% 93/102 |
- - |
- - |
- - |
- - |
| 2010 | -3.38% 12/58 |
- - |
- - |
- - |
- - |
| 2009 | 113.64% 1/27 |
- - |
- - |
- - |
- - |
| 2008 | -63.43% 16/26 |
- - |
- - |
- - |
- - |
| 2007 | 185.28% 1/22 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 易方达深证100ETF VS. 长安沪深300非周期A(740101) |